Candel Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CADL and other ETFs, options, and stocks.

About CADL

Candel Therapeutics, Inc. operates as a biopharmaceutical company that develops and commercializes cancer immunotherapy drugs. It offers aglatimagene besadenovec (CAN-2409), a replication-deficient adenovirus that delivers within infected cancer cells the herpes simplex virus thymidine kinase (HSV-tk) gene. 

CEO
Paul-Peter Tak
CEOPaul-Peter Tak
Employees
65
Employees65
Headquarters
Needham, Massachusetts
HeadquartersNeedham, Massachusetts
Founded
2002
Founded2002
Employees
65
Employees65

CADL Key Statistics

Market cap
96.21M
Market cap96.21M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
27.61K
Average volume27.61K
High today
$3.47
High today$3.47
Low today
$3.18
Low today$3.18
Open price
$3.18
Open price$3.18
Volume
5.24K
Volume5.24K
52 Week high
$11.98
52 Week high$11.98
52 Week low
$2.81
52 Week low$2.81

CADL Earnings

-$0.41
-$0.27
-$0.14
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 11, Pre-Market
ActualExpected Nov 11, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.